These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1187555)

  • 41. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 42. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review.
    Hechtman L
    Psychopharmacol Bull; 1985; 21(2):178-91. PubMed ID: 2860690
    [No Abstract]   [Full Text] [Related]  

  • 43. Minimal cerebral dysfunction.
    Burrows WG
    Nebr State Med J; 1971 Nov; 56(11):444-7. PubMed ID: 4255849
    [No Abstract]   [Full Text] [Related]  

  • 44. Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.
    Wu N; Feng Z; He X; Kwon W; Wang J; Xie XQ
    Sci Rep; 2019 Feb; 9(1):2268. PubMed ID: 30783122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ["The amphetamine treatment helped my child". Is it time to reevaluate Swedish practice in hyperactivity syndrome?].
    Lakartidningen; 1996 Nov; 93(47):4307-8. PubMed ID: 8984302
    [No Abstract]   [Full Text] [Related]  

  • 46. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A drug to ease attention deficit-hyperactivity disorder.
    Smitherman CH
    MCN Am J Matern Child Nurs; 1990; 15(6):362-5. PubMed ID: 2124318
    [No Abstract]   [Full Text] [Related]  

  • 50. Is Captagon (fenethylline) helping to fuel the Syrian conflict?
    Van Hout MC; Wells J
    Addiction; 2016 Apr; 111(4):748-9. PubMed ID: 26787140
    [No Abstract]   [Full Text] [Related]  

  • 51. Jordanian University Students' Lived Experience of Misusing Amphetamine (Captagon): A Qualitative Study.
    Al Omari O; Wynaden D; Alkhawaldeh A; Alhalaiqa F; Al Dameery K; Roach EJ; Sunderraj SJ; Khalaf A
    J Addict Nurs; 2022 Jan-Apr 01; 33(1):20-26. PubMed ID: 35230057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Captagon: use and trade in the Middle East.
    Al-Imam A; Santacroce R; Roman-Urrestarazu A; Chilcott R; Bersani G; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 27766667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Re-activation of the psyche as a drug problem with reference to experiences with the psychotonic Captagon].
    BOERGER HH
    Med Welt; 1962 Mar; 9():493-6. PubMed ID: 13870498
    [No Abstract]   [Full Text] [Related]  

  • 54. MDs discuss concepts of brain dysfunction.
    Am Fam Physician; 1979 May; 19(5):217-8. PubMed ID: 443167
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of instenon in children with minimal brain dysfunction].
    Zavadenko NN; Suvorinova NIu; Rumiantseva MV; Ovchinnikova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(5):29-35. PubMed ID: 12087730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Minimal brain dysfunction syndrome].
    Mizuno T
    Josanpu Zasshi; 1979 Aug; 33(8):552-4. PubMed ID: 259700
    [No Abstract]   [Full Text] [Related]  

  • 57. Megavitamins for minimal brain dysfunction. A potentially dangerous therapy.
    Shaywitz BA; Siegel NJ; Pearson HA
    JAMA; 1977 Oct; 238(16):1749-50. PubMed ID: 578271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [CAPTAGON AS AN ADDICTING DRUG].
    GRAHMANN H; REIMER F
    Nervenarzt; 1965 May; 36():227-8. PubMed ID: 14305717
    [No Abstract]   [Full Text] [Related]  

  • 59. [Minimal brain dysfunction syndrome].
    Suzuki M
    Nihon Rinsho; 1977; 35 Suppl 1():704-5. PubMed ID: 612959
    [No Abstract]   [Full Text] [Related]  

  • 60. Hyperkinetic impulse disorder in children's behavior problems.
    DENHOFF E; LAUFER MW; SOLOMONS G
    Psychosom Med; 1957; 19(1):38-49. PubMed ID: 13400991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.